Page last updated: 2024-08-22

vidarabine and Hemoglobinopathies

vidarabine has been researched along with Hemoglobinopathies in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, KW; Chaudhury, S; Douglas, D; Gilman, AL; Hale, GA; Haut, P; Hayashi, RJ; Kasow, KA; Madden, LM; Murray, LM; Pulsipher, MA; Shenoy, S	1
Blumberg, N; Fenton, P; Horan, JT; Liesveld, JL; Walters, MC	1
Aschan, J; Barkholt, L; Dahllöf, G; Gustafsson, B; Hassan, Z; Ljungman, P; Mattsson, J; Omazic, B; Remberger, M; Ringdén, O; Svahn, BM; Svenberg, P; Uzunel, M; Winiarski, J	1

Trials

1 trial(s) available for vidarabine and Hemoglobinopathies

Article	Year
Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone marrow transplantation, 2005, Volume: 35, Issue:2 Topics: Adolescent; Adult; Anemia, Sickle Cell; Antilymphocyte Serum; Child; Combined Modality Therapy; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinopathies; Humans; Immunosuppressive Agents; Infections; Male; Pancytopenia; Thalassemia; Transfusion Reaction; Transplantation Chimera; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation	2005

Article

Year

Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.

Bone marrow transplantation, 2005, Volume: 35, Issue:2

Topics: Adolescent; Adult; Anemia, Sickle Cell; Antilymphocyte Serum; Child; Combined Modality Therapy; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinopathies; Humans; Immunosuppressive Agents; Infections; Male; Pancytopenia; Thalassemia; Transfusion Reaction; Transplantation Chimera; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

2005

Other Studies

2 other study(ies) available for vidarabine and Hemoglobinopathies

Article	Year
Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:8 Topics: Adolescent; Adult; Alemtuzumab; Bone Marrow Transplantation; Child; Child, Preschool; Female; Follow-Up Studies; Graft Survival; Hemoglobinopathies; Humans; Male; Melphalan; Myeloablative Agonists; Stem Cell Transplantation; Survival Analysis; Transplantation Conditioning; Vidarabine; Young Adult	2016
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases. Bone marrow transplantation, 2007, Volume: 39, Issue:7 Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinopathies; Humans; Immunologic Deficiency Syndromes; Infant; Male; Middle Aged; Transplantation Conditioning; Vidarabine	2007

Article

Year

Long-Term Follow-Up after Reduced-Intensity Conditioning and Stem Cell Transplantation for Childhood Nonmalignant Disorders.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:8

Topics: Adolescent; Adult; Alemtuzumab; Bone Marrow Transplantation; Child; Child, Preschool; Female; Follow-Up Studies; Graft Survival; Hemoglobinopathies; Humans; Male; Melphalan; Myeloablative Agonists; Stem Cell Transplantation; Survival Analysis; Transplantation Conditioning; Vidarabine; Young Adult

2016

Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.

Bone marrow transplantation, 2007, Volume: 39, Issue:7

Topics: Adolescent; Adult; Anemia, Aplastic; Antineoplastic Agents; Child; Child, Preschool; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinopathies; Humans; Immunologic Deficiency Syndromes; Infant; Male; Middle Aged; Transplantation Conditioning; Vidarabine

2007